Introduction
Oral cancer is a wide term that includes various forms of malignancy presenting in the oral cavity. [1] It is one of the sixth most common cancers in Asia (3% of malignancy) and affects nearly 300,000 patients each year. [2] Squamous cell carcinoma (SCC) is the most frequent oral cancer with different tissue presentations.
[3] The 5-year survival rate of early-detected oral cancer is 80%, although for advanced lesions, this number decreases to nearly 30-50%. [4] Moreover, treatment modalities often influence the speech, nutrition, and swallowing. [5] Patients' fear, asymptomatic primary lesions, and misdiagnosis result in delayed diagnosis. [6] Oral premalignant lesion such as leukoplakia, erythroplakia and oral lichen planus (OLP) may convert into oral cancer. [7] OLP is a chronic inflammatory disease of the oral mucosa, which seems to be associated with the process of cell-mediated immunity. [8] Prevalence of oral lesions is reported to be 0.5-2.2 percent. [9] The risk of malignant transformation is low and the incidence is nearly 0.2% per year. [3] Early detection of oral cancer and precancerous lesions can significantly improve the patient's survival and decrease the morbidity. [6] Definitive diagnosis of potentially malignant and malignant lesions is through tissue biopsy and histopathology. However, some approaches such as oral brush biopsy, vital tissue staining, and light technology are suggested as diagnostic aids. Cytology was used to evaluate the morphology of epithelial cells, [10] but the primary results were not satisfactory because the cotton-tipped tool could only separate the surface cells. Subsequently, the brush cytology was introduced that can separate all the three layers of epithelium, [2] and allows assessment of both morphology and keratinization. This method is 95% accurate, with a painless procedure that requires no anesthesia.
[11] Different studies have used the oral brush biopsy for the diagnosis of malignant lesions. [2, [12] [13] The sensitivity of this method was reported to be in the range of 71% to 97.2%. [14] [15] Consequently, to increase the diagnostic accuracy of cytology, various methods were used such as bio-molecular techniques and determining the mutation. [16] [17] [18] [19] Ki-67 is a protein that is detected on phases G1, S, G2, M cell cycle (not on G0 phase). [20] It is known as a cell proliferation factor. In premalignant lesions, expression of this factor was reported to increase with severity of the dysplasia. [9] Main chromosome maintenance (MCM) is another protein that plays a key role in the initiation and continuation of DNA replication [21] and includes six sub-groups (MCM 2 to MCM 7). [22] paradox has yet to be resolved. MCM3AP is a splice variant of a much larger protein called GANP that is found in B cells. The association of GANP with DNA primase activity suggests its involvement in the regulation of B-cell proliferation. [21] [22] According to the basic role of this protein in the regulation of DNA replication and cell proliferation, it seems that the MCM is one of the important markers of cell cycle. [22] Some studies have also reported MCM3 as a diagnostic marker in human tumors. [23] Nonetheless, only one study has evaluated expression of Ki-67 markers and no study had assessed MCM3 on cytology samples. Therefore, the aim of this study was to evaluate and compare the ki-67 and MCM3 expression in cytologic smear of OSCC samples.
Materials and Method

Sampling
By using toothbrush, oral brush biopsies were obtained 
Results
Out of 48 samples, 25 cases were male and 23 were female with the mean age of 47.25 (Table 1) . Table 2 ).
Discussion
Various types of mucosal lesions frequently develop in oral cavity, a small number of which exhibit the potential to become malignant tumors. [24] Oral cancers are the most prevalent malignancies in the head and neck region, especially in developing countries where many individuals are affected by irritants and carcinogenic agents including tobacco smoke and betel nut extract.
[25]
Identification of small malignant or premalignant lesion plays an imperative role in improving the diagnosis and treatment of cancers. Surgical biopsy is the best and most accurate technique for diagnosis of oral cavity lesions; however, it cannot be applied for some patients. [24] Exfoliative cytology technique is a simple noninvasive method used to investigate the mucosal surface epithelial cells; it is referred to as the conventional cytologic smear technique. Initially, it was introduced to detect the cervical cancers at early stages.
Nonetheless, it has limited applications in oral medicine [26] because contrary to the cervix uteri, the oral mucosa does not exhibit a transformation zone for the squamous and glandular epithelia to meet. Therefore, the atypical cells can be detectable in the deeper layer or at the surface of the lesions in later stages. [24] Consequently, the reliability of brush cytology procedures should be improved by employing supportive techniques such as DNA cytometry, automated image analysis, immunocytochemistry, and molecular biolog-ical tests. [19] Epithelial dysplasia and malignancy exhibit ectopic cell cycles as an important feature [27] To the best of our knowledge, there was no similar study evaluating the MCM3 in brush biopsy. Our result reported the MCM3 biomarker to be more sensitive than Ki-67 for cytological evaluation of OSCC.
Differences between the expression of MCM3 and Ki-67 might be attributed to the differences in the expression of these markers in the cell cycle; i.e. MCM3 was expressed later in the cycle. Expression of MCM3 is reported in the early G1 phase and in the entire cell cycle; while, the expression of Ki-67 is reported in the late G1 to M phases. [23] The limitation of the present study was the contamination of the specimen with blood, bacteria, necrotic or proteinaceous debris that can be eliminated by employing liquid-based technique.
Conclusion
The present study found that Ki-67 and MCM3 immunocytology could be used for early detection of OSCC. The results also revealed that MCM3 is a more sensitive cytologic biomarker than Ki-67.
